Pfizer Unit Can't Force Actavis To Alter Generic Drug Label
A British patent court ruled Wednesday that Pfizer unit Warner-Lambert Co. LLC cannot force Actavis UK Ltd. to place a notice on the packaging of its upcoming generic version of Lyrica...To view the full article, register now.
Already a subscriber? Click here to view full article